Capsule formulations require fewer processing steps than tablet formulations, meaning less time for process optimization, documentation and equipment validation. And when early phase clinical trials are conducted in capsules, there is no need for the time consuming bioequivalence testing that would be needed to develop the commercial dose in a tablet. Plus capsule formulations require fewer excipients than tablets, so there is less time needed to select, evaluate, and validate raw materials.

And when dealing with poorly soluble compounds, the capsule is the dosage form of choice as it can be easily filled with liquids and semi-solids for clinical trials and commercial production.

Time saved using formulations developed for capsule delivery systems translates directly into more selling time for actives protected by patent, making the capsule dosage form decision not only simple, but smart.

Let Capsugel help you achieve 'Faster Time to First-In-Man'TM

Our precision powder micro-dosing system, offered in two automated benchtop models, precisely fills capsules with drug substances alone, thereby eliminating the need for excipient compatibility and preformulation activities. Learn More		Allows formulation scientists the ability to more easily exploit the potential of lipid-based formulations for poorly soluble compounds by liquid filling and sealing clinical trial batches in LicapsŪ capsules. Learn More
Our team of formulation experts is ready to assist you with developing formulations using promising, but poorly soluble actives, into your next blockbuster product. Learn More

To speak with a Capsugel representative in your area or for a demonstration of these technologies, click here.